Nalinda B Wasala

Title: Nalinda B Wasala: Innovator in CRISPR Therapy

Introduction

Nalinda B Wasala is a prominent inventor based in Columbia, MO (US). He has made significant contributions to the field of genetic engineering, particularly through his work on CRISPR therapy. His innovative approaches have the potential to revolutionize the treatment of genetic conditions.

Latest Patents

Nalinda B Wasala holds 1 patent related to CRISPR therapy. The patent discloses methods for systemically editing a gene in a subject and for treating a genetic condition using a dual-vector CRISPR-Cas therapy. The methods involve administering a gene editing AAV vector encoding a CRISPR effector protein and a targeting AAV vector providing one or more gRNAs targeted to the gene. Notably, the ratio of the targeting AAV vector to the gene editing vector is greater than or equal to 2. This dual-vector system offers a promising approach for editing genes or treating genetic diseases.

Career Highlights

Throughout his career, Nalinda B Wasala has worked with esteemed institutions, including the University of Missouri and the United States Department of Health and Human Services. His work has been instrumental in advancing the understanding and application of CRISPR technology in therapeutic settings.

Collaborations

Nalinda has collaborated with notable colleagues such as Chady Hakim and Dongsheng Duan. Their combined expertise has contributed to the development of innovative solutions in genetic therapy.

Conclusion

Nalinda B Wasala's contributions to CRISPR therapy exemplify the impact of innovative thinking in the field of genetics. His work continues to pave the way for advancements in the treatment of genetic conditions.